The Molecular Profiling Lottery: More Accuracy, Less Precision, and No Cost.

The Molecular Profiling Lottery: More Accuracy, Less Precision, and No Cost.

Clin Cancer Res. 2018 Dec 04;:

Authors: Ratain MJ

Abstract
The concept of complete molecular profiling to select investigational treatment options is appealing; theoretically allowing the matching of patients to investigational drugs specifically targeted to molecular features of each patient's cancer. While some patients do benefit from such a strategy, the vast majority do not.

PMID: 30514776 [PubMed - as supplied by publisher]

from PubMed via alexandrossfakianakis on Inoreader https://ift.tt/2Qflw6J